N/A
N=161
Virtual Immersive Communication Training on Recommending Immunizations
Human Papilloma Virus
Bottom Line
View on ClinicalTrials.gov: NCT04368455 ↗Enrolled (actual)
161
Serious AEs
0.0%
Results posted
Apr 2023
Primary outcome: Primary: Percent Change From Baseline in the Percentage of Participants With HPV Vaccine Initiation — 18.1; 3.9 Percent Change from Baseline
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Virtual Immersive Communication Training on Recommending Immunizations (VICTORI) (Behavioral); HPV Same Way Same Day App (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Brittany Rosen
- Primary completion
- Mar 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percent Change From Baseline in the Percentage of Participants With HPV Vaccine Initiation |
18.1; 3.9 | — |
| SECONDARY Physicians Perceived Barriers |
7.39; 6.87; 6.75 | — |
| SECONDARY Physicians Perceived Risk |
10.53; 12.07; 11.36 | — |
| SECONDARY Physicians Attitudes Toward the HPV Vaccine |
49.68; 54.24; 53.15 | — |
| SECONDARY Physicians Strength of Recommendation of the HPV Vaccine |
28.49; 28.76; 29.17 | — |
| SECONDARY Physicians Self-efficacy |
7.44; 9.55; 9.27 | — |
Summary
Our approach will be to implement Virtual Immersive Communication Training on Recommending Immunizations (VICTORI), an intervention that includes a self-directed app based curriculum and VR simulations, designed to increase the strength and consistency of HPV vaccine recommendations among clinicians. A single-site intervention assessing the efficacy of VICTORI in increasing HPV vaccine rates will be conducted.
Eligibility Criteria
Inclusion Criteria
- Physician (Attending or Resident) at control or intervention clinic
- Staff Member (Medical Assistant or Nurse) at intervention clinic
Exclusion Criteria
- N/A
Data sourced from ClinicalTrials.gov (NCT04368455). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.